Ensysce Biosciences Inc

Research Ensysce Biosciences Inc (ENSC) on Bullrun: market cap USD 4.36M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerENSC
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 4.36M
• Financial periodFY2025
• RevenueUSD 5.07M
• Revenue growth-2.8%
• Net income-USD 10.18M
• Free cash flow-USD 7.93M

Valuation Snapshot

latest market cap is USD 4.36M.

About Ensysce Biosciences Inc

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology.

Frequently asked questions

What is Ensysce Biosciences Inc's market cap?

Ensysce Biosciences Inc's market capitalization is USD 4.36M.

What does Ensysce Biosciences Inc do?

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.